News
1d
Medpage Today on MSNTargeted Treatment Improves Disability in Guillain-Barre SyndromeThe primary endpoint, outcome on the GBS Disability Score (GBS-DS) at 8 weeks, showed 29% of patients treated with ...
As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another ...
Former Beltrami jail nurse Michelle Skroch made her first appearance in court Friday. She’s charged with criminal neglect and ...
2d
FOX 9 Minneapolis-St. Paul on MSNEx-Beltrami jail nurse charged in Hardel Sherrell's death asks to report to different jailA former Beltrami County Jail nurse appeared in court Friday morning for a manslaughter charge stemming from the death of Hardel Sherrell.
An unhealthy gut might be fuelling deadly nerve attacks. Here are diet tips to reduce the risk of Guillain-Barré Syndrome ...
Annexon, Inc. (NASDAQ:ANNX) on Tuesday presented data for its late-stage targeted therapy, tanruprubart (formerly ANX005), ...
To beef up its case for tanruprubart, Annexon also announced on Wednesday that a real-world study of the drug likewise showed a “rapid increase in muscle strength” versus current standards of care in ...
We recently published a list of 10 Stocks Fall Behind Amid Market Optimism. In this article, we are going to take a look at ...
Five-year-olds can be goofy. That was my first thought several years ago when my son stumbled and fell to the ground.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results